Top Companies in Thailand Sertraline Market | Key Players & Insights 2026

Thailand Sertraline Market Overview

According to 6Wresearch, the Thailand sertraline market is expanding rapidly, driven by the expansion of the "Universal Coverage Scheme" and rising public awareness of mental health conditions. Sertraline is preferred as a first-line treatment for Major Depressive Disorder (MDD) and Panic Disorder due to its favorable safety profile and cost-effectiveness. The integration of psychiatric care into primary health care centers, as well as the growing use of digital health platforms for remote consultation and prescription refills, are also contributing to the growth of the industry.

Competitive Landscape

The competitive landscape of the Thailand sertraline market is shaped by stringent Thai FDA regulations and the push for PIC/S GMP compliance. Domestic manufacturers compete by securing National List of Essential Medicines (NLEM) status, assures large-volume procurement for public hospitals.

Below is a list of leading players operating in the Thailand Sertraline Market:

1. The Government Pharmaceutical Organization (GPO)

The primary state entity responsible for ensuring the availability of essential psychiatric medications, providing affordable sertraline through the public healthcare system.

2. Siam Pharmaceutical Co., Ltd.

A major domestic leader that offers high-quality generic SSRIs, maintaining a significant share in the hospital procurement and retail pharmacy segments.

3. Biolab Co., Ltd.

A member of the Biopharm Group, Biolab specializes in the production of complex generics, including neuropsychiatry drugs, with a focus on high-purity synthesis.

4. Millimed Co., Ltd.

A modern manufacturer known for its robust range of oral solid dosages, supplying effective sertraline variants to the domestic Thai market.

5. Thai Nakorn Patana Co., Ltd.

A retail powerhouse that leverages its extensive distribution network to make chronic medications accessible to consumers across Thailand.

6. Siam Bheasach Co., Ltd.

Specializes in generic medicines for the domestic hospital segment, known for its reliable supply of essential antidepressants.

7. T.O. Chemicals Ltd.

Part of the T.O. Pharma Group, this firm provides high-volume production of neuropsychiatric drugs with international quality certifications.

8. Macrophar Co., Ltd.

A key contributor to the generic market, developing cost-optimized sertraline tablets that meet the widespread needs of Thai clinical practice.

9. Berlin Pharmaceutical Industry Co., Ltd.

A pioneer in the Thai pharmaceutical industry, Berlin Pharma focuses on chronic care and maintains high-standard manufacturing for its CNS portfolio.

10. A.N.B. Laboratories Co., Ltd.

Under the BDMS Group, A.N.B. focuses on high-quality pharmaceutical production, ensuring that specialized hospital segments receive reliable medication.

11. Pfizer (Thailand) Ltd.

As the innovator of the brand Zoloft, Pfizer maintains a premium presence in Thailand, serving the specialty private hospital segment.

12. Viatris

Manages a diverse portfolio of off-patent medications in Thailand, providing high-standard sertraline through its legacy Upjohn and Mylan divisions.

13. Sun Pharma Ltd.

Leverages global neuropsychiatry expertise to supply specialized psychiatric products to private clinics and large-scale hospitals in Bangkok.

14. Lupin Limited

A significant generic exporter to the ASEAN region, supplying high-quality sertraline to meet the therapeutic consistency required by Thai clinicians.

15. Vesco Pharmaceutical Co., Ltd.

Focuses on the production of essential generics for both the local and regional markets, ensuring stable supply chains for chronic therapies.